The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
High-Sensitivity C-Reactive Protein and Cardiovascular Disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 3,503
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436
Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease
Cohen, J. C., Boerwinkle, E., Mosley, T. H., & Hobbs, H. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054013 · Cited by 3,181
Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups
Detrano, R., Guerci, A. D., Carr, J. J., Bild, D. E., Burke, G., Folsom, A. R., Liu, K., Shea, S., Szklo, M., Bluemke, D. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa072100 · Cited by 2,989
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
C-Reactive Protein Levels and Outcomes after Statin Therapy
Ridker, P. M., Cannon, C. P., Morrow, D., Rifai, N., Rose, L. M., McCabe, C. H., Pfeffer, M. A., & Braunwald, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042378 · Cited by 2,292 · cited 3×
“Atorvastatin reduced hsCRP and LDLC levels by 38% and 35%, respectively (21).”
BackgroundMethodDanesh, J., Collins, R., Appleby, P., & Peto, R. (1998) · JAMA · doi:10.1001/jama.279.18.1477 · Cited by 2,026
Writing Committee Members, Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3182051b4c · Cited by 1,873
Self-citationRidker, P. M., Buring, J. E., Rifai, N., & Cook, N. R. (2007) · JAMA · doi:10.1001/jama.297.6.611 · Cited by 1,814
Graham (2007) · doi:10.1097/01.hjr.0000277983.23934.c9 · Cited by 1,647
Mancia, G., Laurent, S., Agabiti-Rosei, E., Ambrosioni, E., Burnier, M., Caulfield, M. J., Cifkova, R., Clément, D., Coca, A., Dominiczak, A., et al. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e328333146d · Cited by 1,643
Ridker, P. M., Rifai, N., Clearfield, M., Downs, J. R., Weis, S. E., Miles, J. S., & Gotto, A. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442601 · Cited by 1,557
Prevalence of Conventional Risk Factors in Patients With Coronary Heart Disease
Khot, U. N. (2003) · JAMA · doi:10.1001/jama.290.7.898 · Cited by 1,494
Serological reactions in pneumonia with a non-protein somatic fraction of Pneumococcus
Tillett, W. S., & Francis, T. (1930) · Journal of Experimental Medicine · doi:10.1084/jem.52.4.561 · Cited by 1,482
Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F. M., Moye, L. A., Goldman, S., Flaker, G. C., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.98.9.839 · Cited by 1,389
Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
Kamstrup, P. R. (2009) · JAMA · doi:10.1001/jama.2009.801 · Cited by 1,357 · cited 1×
“In contrast, similar Mendelian analyses of LDL-C and lipoprotein(a) are compatiblewith causal effects inCHD(35,36).”
Resultde Lemos, J. A., Blazing, M. A., Wiviott, S. D., Lewis, E. F., Fox, K. A. A., White, H. D., Rouleau, J.-L., Pedersen, T. R., Gardner, L. H., Mukherjee, R., et al. (2004) · JAMA · doi:10.1001/jama.292.11.1307 · Cited by 1,333
Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease
Nissen, S. E., Tuzcu, E. M., Schoenhagen, P., Crowe, T., Sasiela, W. J., Tsai, J., Orazem, J., Magorien, R. D., O'Shaughnessy, C., & Ganz, P. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042000 · Cited by 1,325
2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., Kushner, F. G., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.001 · Cited by 1,324
Self-citationInflammatory Markers and the Risk of Coronary Heart Disease in Men and Women
Pai, J. K., Pischon, T., Ma, J., Manson, J. E., Hankinson, S. E., Joshipura, K., Curhan, G. C., Rifai, N., Cannuscio, C. C., Stampfer, M. J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040967 · Cited by 1,174
C-reactive protein, fibrinogen, and cardiovascular disease prediction
The Emerging Risk Factors Collaboration (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1107477 · Cited by 1,150
Hlatky, M. A., Greenland, P., Arnett, D. K., Ballantyne, C. M., Criqui, M. H., Elkind, M. S. V., Go, A. S., Harrell, F. E., Hong, Y., Howard, B. V., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192278 · Cited by 1,139
Yeboah, J., McClelland, R. L., Polonsky, T. S., Burke, G. L., Sibley, C. T., O’Leary, D., Carr, J. J., Goff, D. C., Greenland, P., & Herrington, D. M. (2012) · JAMA · doi:10.1001/jama.2012.9624 · Cited by 1,122
Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study
for the MRFIT Research Group, Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,097
Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events
Greenland, P. (2003) · JAMA · doi:10.1001/jama.290.7.891 · Cited by 1,050
Arad, Y., Goodman, K. J., Roth, M., Newstein, D., & Guerci, A. D. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.088 · Cited by 984
Mancia, G., Laurent, S., Agabiti-Rosei, E., Ambrosioni, E., Burnier, M., Caulfield, M. J., Cifkova, R., Clément, D., Coca, A., Dominiczak, A., et al. (2009) · Blood Pressure · doi:10.3109/08037050903450468 · Cited by 894
Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes
Zethelius, B., Berglund, L., Sundström, J., Ingelsson, E., Basu, S., Larsson, A., Venge, P., & Ärnlöv, J. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707064 · Cited by 889
Ridker, P. M., Paynter, N. P., Rifai, N., Gaziano, J. M., & Cook, N. R. (2008) · Circulation · doi:10.1161/circulationaha.108.814251 · Cited by 841
Genetically elevated C-reactive protein and ischemic vascular disease
Zacho, J., Tybjærg-Hansen, A., Jensen, J. S., Grande, P., Sillesen, H., & Nordestgaard, B. G. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707402 · Cited by 839
Ridker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799
Genest, J., McPherson, R., Frohlich, J., Anderson, T., Campbell, N., Carpentier, A., Couture, P., Dufour, R., Fodor, G., Francis, G. A., et al. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)70715-9 · Cited by 768
Ridker, P. M., Rifai, N., & Clearfield, M. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00460-3 · Cited by 760
Shlipak, M. G., Fried, L. F., Cushman, M., Manolio, T. A., Peterson, D., Stehman-Breen, C., Bleyer, A., Newman, A., Siscovick, D., & Psaty, B. (2005) · JAMA · doi:10.1001/jama.293.14.1737 · Cited by 735
Rutter, M. K., Meigs, J. B., Sullivan, L. M., D’Agostino, R. B., & Wilson, P. W. F. (2004) · Circulation · doi:10.1161/01.cir.0000136581.59584.0e · Cited by 664
C Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC) (2011) · BMJ · doi:10.1136/bmj.d548 · Cited by 642
Vigushin, D. M., Pepys, M. B., & Hawkins, P. N. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116336 · Cited by 636
Buckley, D. I., Fu, R., Freeman, M., Rogers, K., & Helfand, M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-7-200910060-00009 · Cited by 559
Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community
Melander, O. (2009) · JAMA · doi:10.1001/jama.2009.943 · Cited by 551
Dehghan, A., Dupuis, J., Barbalic, M., Bis, J. C., Eiriksdottir, G., Lu, C., Pellikka, N., Wallaschofski, H., Kettunen, J., Henneman, P., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.948570 · Cited by 511
The effect of including C-reactive protein in cardiovascular risk prediction models for women
Cook, N. R., Buring, J. E., & Ridker, P. M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-1-200607040-00128 · Cited by 504 · cited 1×
“5% of the total population) into higher-risk (75)da transition that is most likely to alter clinical management in those not on statin therapy.”
BackgroundKoenig, W., Löwel, H., Baumert, J., & Meisinger, C. (2004) · Circulation · doi:10.1161/01.cir.0000120707.98922.e3 · Cited by 445
Pleiotropic Effects of Statins: Benefit Beyond Cholesterol Reduction?
Robinson, J. G., Smith, B., Maheshwari, N., & Schrott, H. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.085 · Cited by 407
Evaluation of Newer Risk Markers for Coronary Heart Disease Risk Classification: A Cohort Study
Kavousi, M., Elias-Smale, S., Rutten, J. H. W., Leening, M. J. G., Vliegenthart, R., Verwoert, G. C., Krestin, G. P., Oudkerk, M., de Maat, M. P. M., Leebeek, F. W. G., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-6-201203200-00006 · Cited by 360
Folsom, A. R., Chambless, L. E., Ballantyne, C. M., Coresh, J., Heiss, G., Wu, K. K., Boerwinkle, E., Mosley, T. H., Sorlie, P., Diao, G., et al. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.13.1368 · Cited by 358
Blaha, M. J., Budoff, M. J., DeFilippis, A. P., Blankstein, R., Rivera, J. J., Agatston, A., O'Leary, D. H., Lima, J., Blumenthal, R. S., & Nasir, K. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60784-8 · Cited by 343
Self-citationAlcohol Consumption and Plasma Concentration of C-Reactive Protein
Albert, M. A., Glynn, R. J., & Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000045669.16499.ec · Cited by 331
Morrow, D. A., de Lemos, J. A., Sabatine, M. S., Wiviott, S. D., Blazing, M. A., Shui, A., Rifai, N., Califf, R. M., & Braunwald, E. (2006) · Circulation · doi:10.1161/circulationaha.106.628909 · Cited by 313
C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study
Wilson, P. W. F., Pencina, M., Jacques, P., Selhub, J., D'Agostino, R., & O'Donnell, C. J. (2008) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.831198 · Cited by 299
Assessing the Role of Circulating, Genetic, and Imaging Biomarkers in Cardiovascular Risk Prediction
Wang, T. J. (2011) · Circulation · doi:10.1161/circulationaha.109.912568 · Cited by 294
Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis
Norata, G. D., Marchesi, P., Pulakazhi Venu, V. K., Pasqualini, F., Anselmo, A., Moalli, F., Pizzitola, I., Garlanda, C., Mantovani, A., & Catapano, A. L. (2009) · Circulation · doi:10.1161/circulationaha.108.806547 · Cited by 277
Narrative Review: Assessment of C-Reactive Protein in Risk Prediction for Cardiovascular Disease
Lloyd-Jones, D. M., Liu, K., Tian, L., & Greenland, P. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-1-200607040-00129 · Cited by 274
Eisenhardt, S. U., Habersberger, J., Murphy, A., Chen, Y.-C., Woollard, K. J., Bassler, N., Qian, H., von zur Muhlen, C., Hagemeyer, C. E., Ahrens, I., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.190611 · Cited by 272
RIDKER, P. M. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03404.x · Cited by 270
Distribution of C-Reactive Protein Values in the United States
Woloshin, S., & Schwartz, L. M. (2005) · New England Journal of Medicine · doi:10.1056/nejm200504143521525 · Cited by 270
Kones, R. (2011) · Drug Design, Development and Therapy · doi:10.2147/dddt.s14934 · Cited by 259
Relation of C-Reactive Protein to Abdominal Adiposity
Brooks, G. C., Blaha, M. J., & Blumenthal, R. S. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.02.017 · Cited by 255
Self-citationWilson, P. W. F., Nam, B.-H., Pencina, M., D’Agostino, R. B., Benjamin, E. J., & O’Donnell, C. J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.21.2473 · Cited by 238
Park, R., Detrano, R., Xiang, M., Fu, P., Ibrahim, Y., LaBree, L., & Azen, S. (2002) · Circulation · doi:10.1161/01.cir.0000033819.29662.09 · Cited by 224
Coronary C-reactive protein distribution: its relation to development of atherosclerosis
Zhang, Y. X., Cliff, W. J., Schoefl, G. I., & Higgins, G. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00105-7 · Cited by 196
Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice
Hirschfield, G. M., Gallimore, J. R., Kahan, M. C., Hutchinson, W. L., Sabin, C. A., Benson, G. M., Dhillon, A. P., Tennent, G. A., & Pepys, M. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503202102 · Cited by 192
The use of high-sensitivity assays for C-reactive protein in clinical practice
Musunuru, K., Kral, B. G., Blumenthal, R. S., Fuster, V., Campbell, C. Y., Gluckman, T. J., Lange, R. A., Topol, E. J., Willerson, J. T., Desai, M. Y., et al. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1322 · Cited by 182
Self-citationClapp, B. R., Hirschfield, G. M., Storry, C., Gallimore, J. R., Stidwill, R. P., Singer, M., Deanfield, J. E., MacAllister, R. J., Pepys, M. B., Vallance, P., et al. (2005) · Circulation · doi:10.1161/01.cir.0000159336.31613.31 · Cited by 181
U.S. Preventive Services Task Force* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-7-200910060-00008 · Cited by 180
Ndumele, C. E., Nasir, K., Conceiçao, R. D., Carvalho, J. A. M., Blumenthal, R. S., & Santos, R. D. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.228262 · Cited by 179
Self-citationMöhlenkamp, S., Lehmann, N., Moebus, S., Schmermund, A., Dragano, N., Stang, A., Siegrist, J., Mann, K., Jöckel, K.-H., & Erbel, R. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.10.043 · Cited by 170
Kinlay, S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.083 · Cited by 166
Ridker, P. M., MacFadyen, J., Libby, P., & Glynn, R. J. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.03.018 · Cited by 160
Heart Protection Study Collaborative Group (2011) · The Lancet · doi:10.1016/s0140-6736(10)62174-5 · Cited by 158
The Value of C-Reactive Protein in Cardiovascular Risk Prediction: The Rotterdam Study
van der Meer, I. M., de Maat, M. P. M., Kiliaan, A. J., van der Kuip, D. A. M., Albert Hofman, D., & Witteman, J. C. M. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.11.1323 · Cited by 156
KONES, R. J. (2010) · Drug Design Development and Therapy · doi:10.2147/dddt.s10812 · Cited by 140
Pepys, M. B., Hawkins, P. N., Kahan, M., Tennent, G. A., Gallimore, J. R., Graham, D., Sabin, C. A., Zychlinsky, A., & de Diego, J. (2005) · Circulation Research · doi:10.1161/01.res.0000193595.03608.08 · Cited by 137
Ji, S., Ma, L., Bai, C., Shi, J., Li, H., Potempa, L. A., Filep, J. G., Zhao, J., & Wu, Y. (2009) · The FASEB Journal · doi:10.1096/fj.08-116962 · Cited by 134
Sattar, N. A., Murray, H. M., McConnachie, A., Blauw, G. J., Bollen, E. L. E. M., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.643114 · Cited by 130
de Lorgeril, M., Salen, P., Abramson, J. D., Dodin, S., Hamazaki, T., Kostucki, W., Okuyama, H., Pavy, B., & Rabaeus, M. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.184 · Cited by 129
van Wissen, S., Trip, M. D., Smilde, T. J., Graaf, J. D., Stalenhoef, A. F. H., & Kastelein, J. J. P. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00280-0 · Cited by 122
Trion, A., de Maat, M. P. M., Jukema, J. W., van der Laarse, A., Maas, M., Offerman, E. H., Havekes, L. M., Szalai, A. J., Princen, H. M. G., & EMEIS, J. J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000171992.36710.1e · Cited by 116
Blaha, M. J., Rivera, J. J., Budoff, M. J., Blankstein, R., Agatston, A. A., O’Leary, D. H., Cushman, M., Gilchrist, S. C., Criqui, M. H., Szklo, M., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.223768 · Cited by 111
Self-citationCurrent and Future Directions of Cardiovascular Risk Prediction
Smith, S. C. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.11.013 · Cited by 107
Human C-Reactive Protein Does Not Promote Atherosclerosis in Transgenic Rabbits
Koike, T., Kitajima, S., Yu, Y., Nishijima, K., Zhang, J., Ozaki, Y., Morimoto, M., Watanabe, T., Bhakdi, S., Asada, Y., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.872796 · Cited by 104
Tennent, G. A., Hutchinson, W. L., Kahan, M., Hirschfield, G. M., Gallimore, J. R., Lewin, J. F., Sabin, C. A., Dhillon, A. P., & Pepys, M. B. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.05.010 · Cited by 100
Intraindividual variability of C-reactive protein: The Multi-Ethnic Study of Atherosclerosis
deGoma, E. M., French, B. C., Dunbar, R. L., Allison, M., Mohler, E. R., & Budoff, M. J. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.07.017 · Cited by 85
Self-citationDiversity of Denizens of the Atherosclerotic Plaque
Libby, P., Nahrendorf, M., Pittet, M. J., & Świrski, F. K. (2008) · Circulation · doi:10.1161/circulationaha.108.783068 · Cited by 80
Blankstein, R., Budoff, M. J., Shaw, L. J., Goff, D. C., Polak, J. F., Lima, J. A. C., Blumenthal, R. S., & Nasir, K. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.01.055 · Cited by 79
Self-citationWithin-Person Variability in High-Sensitivity C-Reactive Protein
Bower, J. K., Lazo, M., Juraschek, S. P., & Selvin, E. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.3712 · Cited by 72
DeFilippis, A. P., Blaha, M. J., Ndumele, C. E., Budoff, M. J., Lloyd‐Jones, D. M., McClelland, R. L., Gilchrist, S. C., Cushman, M., Wong, N. D., Blumenthal, R. S., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.022 · Cited by 72
Self-citationBy Jove! What Is a Clinician to Make of JUPITER?
Kaul, S., Morrissey, R. P., & Diamond, G. A. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.189 · Cited by 68
Lee, K. K., Cipriano, L. E., Owens, D. K., Go, A. S., & Hlatky, M. A. (2010) · Circulation · doi:10.1161/circulationaha.110.947960 · Cited by 65
Sever, P., Poulter, N. R., Chang, C. L., Hingorani, A. D., Thom, S., Hughes, A. D., Welsh, P. I., Sattar, N. A., & on behalf of the ASCOT Investigators (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr262 · Cited by 58
Yang, E. Y., Nambi, V., Tang, Z.-Z., Virani, S. S., Boerwinkle, E., Hoogeveen, R. C., Astor, B. C., Mosley, T. H., Coresh, J., Chambless, L. E., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.006 · Cited by 55
Guan, H., Wang, P., Hui, R., Edin, M. L., Zeldin, D. C., & Wang, D. W. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.115857 · Cited by 54
Gupta, N., de Lemos, J. A., Ayers, C. R., Abdullah, S. M., McGuire, D. K., & Khera, A. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.050 · Cited by 51
Inhibition of Endothelial Nitric Oxide Synthase by C-Reactive Protein: Clinical Relevance
Jialal, I., Verma, S., & Devaraj, S. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.119206 · Cited by 47
Choudhry, N. K., Patrick, A. R., Glynn, R. J., & Avorn, J. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.07.059 · Cited by 45
Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease
Elliott, P. (2009) · JAMA · doi:10.1001/jama.2009.954 · Cited by 35
The JUPITER Trial: Responding to the Critics
Ridker, P. M., & Glynn, R. J. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.08.025 · Cited by 33
Is it important to measure or reduce C-reactive protein in people at risk of cardiovascular disease?
Hingorani, A. D., Sofat, R., Morris, R. W., Whincup, P. H., Lowe, G. D. O., Mindell, J. S., Sattar, N. A., Casas, J. P., & Shah, T. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs168 · Cited by 20
Cited by
Vlachopoulos, C., Xaplanteris, P., Aboyans, V., Brodmann, M., Cífková, R., Cosentino, F., De Carlo, M., Gallino, A., Landmesser, U., Laurent, S., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.05.007 · Cited by 716
“This is attributed to genetic polymorphisms, post-translational mechanisms and presence of comorbidities that can alter baseline values [189].”
BackgroundTargeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation
Marchio, P., Guerra-Ojeda, S., Vila, J. M., Aldasoro, M., Victor, V. M., & Mauricio, M. D. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8563845 · Cited by 621
Role of sleep deprivation in immune-related disease risk and outcomes
Garbarino, S., Lanteri, P., Bragazzi, N. L., Magnavita, N., & Scoditti, E. (2021) · Communications Biology · doi:10.1038/s42003-021-02825-4 · Cited by 571
Blaha, M. J., Cainzos-Achirica, M., Greenland, P., McEvoy, J. W., Blankstein, R., Budoff, M. J., Dardari, Z., Sibley, C. T., Burke, G. L., Kronmal, R. A., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.018524 · Cited by 485
“risk factors for detecting high risk is considered limited.(33) Our findings suggest that the performance of hsCRP as a tool for reassuring the patient and the clinician, when the test result is normal or low, is also limited.”
BackgroundSelf-citationRidker, P. M. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.11.037 · Cited by 414
Metadata
- Authors
- Yousuf, O., Mohanty, B. D., Martin, S. S., Joshi, P. H., Blaha, M. J., Nasir, K., Blumenthal, R. S., & Budoff, M. J.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 62
- Issue
- 5
- Pages
- 397-408
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W115717089
- Cited by
- 494
- References
- 104
- FWCI
- 36.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.